Airgraft
Producer of a cannabis vaporiser aiming to reduce and remove harm from inhalable cannabis products,.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
| investor investor investor | €0.0 | round | |
| N/A | N/A | - | |
| Total Funding | 000k | ||
| USD | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | 28 % | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Airgraft operates in the vaporizer market, offering premium filterless extract vaporizers through a membership-based model. The company targets consumers seeking high-quality vaporizing experiences without nicotine or tobacco. Airgraft's business model revolves around selling its proprietary vaporizers and premium pods exclusively to members, who can order online via Airgraft Xpress. The company generates revenue through membership fees and sales of its vaporizers and pods. Airgraft differentiates itself by providing free delivery on orders over $50 and ensuring a high-quality, nicotine-free, and tobacco-free product. The market for Airgraft includes health-conscious consumers and those looking for a premium vaporizing experience. The company does not produce, extract, distribute, or sell cannabis, focusing solely on the vaporizing device and its pods.
Keywords: vaporizer, premium, filterless, members-only, nicotine-free, tobacco-free, online orders, free delivery, health-conscious, proprietary pods.